OTCMKTS:BAYRY Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis $11.34 +0.29 (+2.62%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BAYRY alerts:Sign Up Key Stats Today's Range$11.20▼$11.4250-Day Range$10.54▼$12.1252-Week Range$6.69▼$14.85Volume5.43 million shsAverage Volume1.45 million shsMarket Capitalization$44.57 billionP/E RatioN/ADividend Yield0.18%Price TargetN/AConsensus RatingBuy Company Overview Bayer Aktiengesellschaft is a global life sciences company headquartered in Leverkusen, Germany, with a history dating back to 1863. The company operates across three principal business areas—Pharmaceuticals, Consumer Health and Crop Science—serving customers and markets worldwide. Bayer develops, manufactures and markets prescription medicines, over-the-counter healthcare products and agricultural solutions, and maintains research and development programs focused on new therapies and technologies in its core fields. In Pharmaceuticals, Bayer focuses on prescription drugs across therapeutic areas such as cardiology, oncology, hematology and women's health, supporting clinical development and regulatory activities for both marketed products and pipeline candidates. Its Consumer Health segment produces and markets nonprescription medicines and self-care products intended for a broad global audience. The Crop Science division supplies seeds, crop protection products and digital farming tools to farmers and agribusinesses, integrating agronomic services with chemical and seed portfolios to address productivity and sustainability challenges. Key historical milestones include the company’s founding in the 19th century and substantial expansion through acquisitions, most notably the 2018 purchase of Monsanto, which significantly expanded Bayer’s seed and crop protection footprint. That acquisition also brought high-profile legal and regulatory matters related to glyphosate-based products, which have been a notable element of the company’s recent corporate history. Bayer conducts operations across Europe, the Americas, Asia-Pacific and other regions, with global manufacturing, research centers and commercial organizations. Bayer is governed by a board of management and a supervisory board and invests heavily in research and development to sustain long-term product pipelines in health and agriculture. The company’s activities emphasize innovation, regulatory compliance and global market presence while navigating complex legal, environmental and commercial landscapes typical for a multinational life sciences firm.AI Generated. May Contain Errors. Read More Bayer Aktiengesellschaft Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreBAYRY MarketRank™: Bayer Aktiengesellschaft scored higher than 60% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingBuy Consensus RatingBayer Aktiengesellschaft has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageBayer Aktiengesellschaft has only been the subject of 3 research reports in the past 90 days.Read more about Bayer Aktiengesellschaft's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.06% Earnings GrowthEarnings for Bayer Aktiengesellschaft are expected to grow by 8.06% in the coming year, from $1.24 to $1.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bayer Aktiengesellschaft is -17.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bayer Aktiengesellschaft is -17.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBayer Aktiengesellschaft has a PEG Ratio of 3.57. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBayer Aktiengesellschaft has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Bayer Aktiengesellschaft's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Bayer Aktiengesellschaft has been sold short.Short Interest Ratio / Days to CoverBayer Aktiengesellschaft has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bayer Aktiengesellschaft has recently decreased by 21.46%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBayer Aktiengesellschaft has a dividend yield of 0.21%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBayer Aktiengesellschaft does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 1.49% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.Read more about Bayer Aktiengesellschaft's dividend. News and Social Media2.7 / 5News Sentiment0.37 News SentimentBayer Aktiengesellschaft has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Bayer Aktiengesellschaft this week, compared to 7 articles on an average week.Search Interest4 people have searched for BAYRY on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows2 people have added Bayer Aktiengesellschaft to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bayer Aktiengesellschaft insiders have not sold or bought any company stock.Percentage Held by InstitutionsBayer Aktiengesellschaft has minimal institutional ownership at this time.Read more about Bayer Aktiengesellschaft's insider trading history. Receive BAYRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAYRY Stock News HeadlinesBayer Tests Digital Heart Monitoring With ACO-Monitor: What Investors Should WatchMay 19 at 12:51 PM | tipranks.comBayer agrees to pay $133 million for PCB cleanup in two statesMay 18 at 3:39 PM | reuters.comThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.May 20 at 1:00 AM | Behind the Markets (Ad)Bayer Advances KRAS G12D Colorectal Cancer Study With New BAY 3771249 TrialMay 18 at 12:50 PM | tipranks.comBayer (0P6S) Gets a Buy from UBSMay 14, 2026 | theglobeandmail.comBayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comBayer AG (BAYRY) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Cash Flow ChallengesMay 14, 2026 | finance.yahoo.comBayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural CommunitiesMay 13, 2026 | businesswire.comSee More Headlines BAYRY Stock Analysis - Frequently Asked Questions How have BAYRY shares performed this year? Bayer Aktiengesellschaft's stock was trading at $10.82 at the beginning of the year. Since then, BAYRY shares have increased by 4.8% and is now trading at $11.34. How were Bayer Aktiengesellschaft's earnings last quarter? Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its earnings results on Tuesday, May, 12th. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.15. The firm had revenue of $15.73 billion for the quarter, compared to analysts' expectations of $15.77 billion. Bayer Aktiengesellschaft had a positive trailing twelve-month return on equity of 17.74% and a negative net margin of 4.75%. Does Bayer Aktiengesellschaft have any subsidiaries? The following companies are subsidiaries of Bayer Aktiengesellschaft: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and others. How do I buy shares of Bayer Aktiengesellschaft? Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/12/2026Today5/20/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Large Cap Pharma Sub-IndustryN/A Current SymbolOTCMKTS:BAYRY CIK1144145 Webwww.bayer.com Phone49214301Fax49-21-4306-6328Employees88,078Year Founded1863Profitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E Ratio9.07 P/E Growth3.52Net Income-$4.10 billion Net Margins-4.75% Pretax Margin-6.87% Return on Equity17.74% Return on Assets4.88% Debt Debt-to-Equity Ratio1.22 Current Ratio1.01 Quick Ratio0.63 Sales & Book Value Annual Sales$51.55 billion Price / Sales0.86 Cash Flow$2.24 per share Price / Cash Flow5.06 Book Value$7.50 per share Price / Book1.51Miscellaneous Outstanding Shares3,930,000,000Free FloatN/AMarket Cap$44.57 billion OptionableNot Optionable Beta0.62 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:BAYRY) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSpaceX did a 5-for-1 split before its IPO - here's whySpaceX just cut its share price from over $526 to roughly $105 with a 5-for-1 stock split - a move that signal...NXT Wave Research | SponsoredFed story no one is tellingJ.P. Morgan's Private Bank quietly advised 333 billionaire families to move 60% of their portfolios into alter...TradeSmith | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
